Clinical Trial Update: Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the use of beta blockers and fracture risk in patients with primary osteoporosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Beta Blocker Toxicity | Phase 3 | Status: RECRUITING